ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer

Blacktown Hospital, Darlinghurst

Macquarie University Hospital, Westmead

Seoul National University Hospital, Seoul

Linear Clinical Research Limited, Nedlands

Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo

Hôpital de la Timone Centre d'essais en cancérologie de Marseille (CEPCM-CLIPP), Marseille

Centre Francois Baclesse, Caen

The Catholic University of Korea, St. Vincent's Hospital, Suwon

Unità Operativa Oncologia medica ed Ematologia, Rozzano

Fondazione IRCCS San Gerardo dei Tintori, Monza

Centre Georges François Leclerc, Dijon

NEXT/Virginia Cancer Specialists, Fairfax

Hospital Universitari Arnau de Vilanova, Lleida

Hospital Universitario Fundación Jiménez Díaz, Madrid

Hospital Universitario 12 de Octubre, Madrid

Advent Health Orlando, Orlando

EDOG - Institut Bergonie - PPDS, Bordeaux

SOC Oncologia Medica e dei Tumori lmmunocorrelati, Centro Di Riferimento Oncologico Di Aviano (CRO) IRCCS, Aviano

BRCR Medical Center Inc, Plantation

Hôpital Pontchaillou, Rennes

Taichung Veterans General Hospital, Taichung

Hospital Universitario Virgen Macarena, Seville

Fundación Instituto Valenciano de Oncología, Valencia

Hospital Universitari i Politècnic La Fe, Valencia

Azienda Ospedaliero Universitaria delle Marche, Ancona

Centre Léon Berard, Lyon

University of Colorado - Anschutz Medical Campus - PPDS, Aurora

Institut Gustave Roussy (IGR), Villejuif

Dana Farber Cancer Institute, Boston

Fondazione Policlinico Universitario A. Gemelli, Roma

Gachon University Gil Medical Center, Incheon

Korea University Anam Hospital, Seoul

National Chen Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Severence Hospital, Yonsei University, Seoul

Samsung Medical Center, Seoul

START Barcelona Hospital HM Nou Delfos, Barcelona

Hospital Universitari Vall d'Hebrón, Barcelona

lnstitut Catala d'Oncologia (ICO) L'Hospitalet, Servicio de Oncologia Medica, L'Hospitalet de Llobregat